{
    "nct_id": "NCT06394869",
    "official_title": "Cystoscopic REDuction In BLadder Evaluations for Microhematuria - A Prospective Randomized, Controlled, Clinical Utility Study for Evaluation of Microhematuria (The CREDIBLE Study)",
    "inclusion_criteria": "1. Patient is referred for assessment of microhematuria (MH) with presentation confirmed by urine microscopy of 3 or more red blood cells per high powered field (RBC/HPF) (documented by the referring physician or at the investigator site) within 90 days of enrollment.\n2. Physically able to provide a voided urine sample from a bladder that has not been surgically altered.\n3. Able to give informed, written consent.\n4. Able and willing to comply with study requirements.\n5. Aged 18 to 88 years.\n6. Ability to comprehend written and spoken English sufficiently to independently follow all study procedures. Or ability to comprehend Spanish with access to an English-Spanish interpreter for all study related verbal instructions and discussions.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 88 Years",
    "exclusion_criteria": "1. Prior history of bladder malignancy.\n2. Prior history of upper tract UC or prostatic urethral UC.\n3. Gross hematuria within the last six months (reported in patient's records and/or during patient's interview)\n4. Reconstructed or diverted bladder (e.g., bladder augmentation, ileal conduit, Indiana pouch)\n5. Indication to recommend cystoscopy other than MH (e.g., bothersome benign prostatic hyperplasia symptoms and desires a procedure, weak stream with concerns for urethral stricture).\n6. Cystoscopy contraindicated due to another condition or anatomy.\n7. History of pelvic radiation.\n8. Currently receiving chemotherapy or has had chemotherapy within the last 6 weeks.\n9. History of schistosomiasis.\n10. History of chronic (>3 months) indwelling Foley catheter or chronic (>3 months) bladder stones.\n11. Known current pregnancy",
    "miscellaneous_criteria": ""
}